Stock Report

Morepen Laboratories Ltd consolidated Q3 FY24 net profit higher at Rs. 31.99 crores

Posted On : 2024-01-31 22:59:27( TIMEZONE : IST )

Morepen Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2023.

Financial Results (Q3 FY2024) - QoQ Comparison

The company has reported total income of Rs. 448.6249 crores during the period ended December 31, 2023 as compared to Rs. 425.0058 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs. 31.9906 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 21.2558 crores for the period ended September 30, 2023.

The company has reported EPS of Rs. 0.63 for the period ended December 31, 2023 as compared to Rs. 0.42 for the period ended September 30, 2023.

Financials	Q3 FY2024	Q2 FY2024	% Change
Total Income	₹ 448.6249 crs	₹425.0058 crs	5.56%
Net Profit	₹31.9906 crs	₹21.2558 crs	50.50%
EPS	₹0.63	₹0.42	50.00%

Financial Results (Q3 FY2024) - YoY Comparison

The company has reported total income of Rs. 448.6249 crores during the period ended December 31, 2023 as compared to Rs.349.6881 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.31.9906 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.8.9932 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.0.63 for the period ended December 31, 2023 as compared to Rs.0.16 for the period ended December 31, 2022.

Financials	Q3 FY2024	Q3 FY2023	% Change
Total Income	₹ 448.6249 crs	₹349.6881 crs	28.29%
Net Profit	₹31.9906 crs	₹8.9932 crs	255.72%
EPS	₹0.63	₹0.16	293.75%

Financial Results (9 Months Ended FY2024) - YoY Comparison

The company has reported total income of Rs.1277.0868 crores during the 9 Months period ended December 31, 2023 as compared to Rs.1056.8554 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.67.8793 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.30.4340 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.1.33 for the 9 Months period ended December 31, 2023 as compared to Rs.0.60 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended FY2024	9 Months Ended FY2023	% Change
Total Income	₹1277.0868 crs	₹1056.8554 crs	20.84%
Net Profit	₹67.8793 crs	₹30.4340 crs	123.04%
EPS	₹1.33	₹0.60	121.67%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 52.81 as compared to the previous close of Rs. 46.64. The total number of shares traded during the day was 3002413 in over 10321 trades.

The stock hit an intraday high of Rs. 53.58 and intraday low of 46.62. The net turnover during the day was Rs. 152678782.00.